Saturday 17 October 2026
Export AKAN’s income statement to Excel — free account
Akanda Corp.
AKAN Healthcare Drug Manufacturers Specialty & Generic
Akanda Corp.’s revenue for fiscal 2025 (year ended December 2025) was $258,100.00, down 69.2% from fiscal 2024. Insiders bought in the last twelve months.
1.20
0.11
−8.40%
Follow AKAN
| Jan '19 | Jan '20 | Dec '20 | Jan '21 | Dec '21 | Jan '22 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | 5 | — | 6 | 2 | 6 | 1 |
Altman Z-Score |
— | — | — | — | — | — | (2.36) | (10.81) | (11.25) | (26.39) |
P/S ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | (13.55) | (11.12) | — | (11.25) | — | (3.83) | (28.99) | (24.68) | (63.09) |
Beneish M-Score |
— | — | — | — | — | — | 52.90 | (1.04) | (0.76) | — |
P/Operating CF |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/B ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.11) | (0.17) | 0.11 | (0.91) |
EV/FCF |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.11) | (0.17) | 0.08 | (0.68) |
Quick Ratio |
— | 0.00 | 0.00 | 0.45 | 0.45 | 0.19 | 0.19 | 0.04 | 1.28 | 0.31 |
Current Ratio |
— | 0.05 | 0.05 | 0.48 | 0.48 | 0.41 | 0.41 | 0.18 | 1.39 | 0.58 |
Net Debt/EBITDA |
0.00 | (6.71) | (6.23) | (2.69) | (2.49) | (0.19) | (0.19) | 6.03 | 0.96 | (2.75) |
Debt/Assets |
— | 213.41% | 206.77% | 118.91% | 113.44% | 10.00% | 9.45% | 43.70% | 4.46% | 209.72% |
Debt/Equity |
— | (1.81) | (1.76) | (4.35) | (4.15) | 0.15 | 0.14 | (1.01) | 0.08 | (1.08) |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.11 | 0.02 | 0.10 | 0.04 |
Operating CF/Net income |
0.46 | 0.59 | 0.59 | 0.81 | 0.81 | 0.98 | 0.98 | 0.05 | 0.97 | 0.15 |
Capex/Depreciation |
0.00 | 0.00 | (1.77) | 0.00 | (1.87) | 0.00 | (0.08) | 0.03 | (5.21) | (2.84) |
Interest Coverage |
(3.65) | (4.90) | (2.58) | (122,412.00) | (244.78) | (47,538.89) | (174.99) | (30.14) | (49.69) | (5.39) |
| 0.00% | 0.00% | 45.72% | 0.00% | 224.83% | 0.00% | (94.40%) | (279.79%) | (1,830.21%) | 1,183.68% | |
| 0.00% | (107.64%) | (53.82%) | 0.00% | (131.99%) | 0.00% | (49.56%) | (134.94%) | (48.90%) | (647.13%) | |
ROIC |
— | 0.00% | (27.44%) | 0.00% | (46.82%) | 0.00% | (41.94%) | 0.00% | (319.90%) | (624.17%) |
Return on Tangible Assets |
0.00% | (188.28%) | 235.26% | 1,688.72% | 340.16% | (167.57%) | (175.76%) | 552.03% | (109.01%) | 19,720.95% |
Average Days of Receivables |
— | 0.00 | 0.00 | 2,137.10 | 2,137.10 | 172.15 | 172.15 | 245.09 | 358.63 | 1,979.85 |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 46,852.38% | 28,790.48% | 2,596.14% | 3,274.64% | 424.84% | 461.42% | 191.15% | 181.07% | 1,135.18% |
Intangible Assets out of Total Assets |
— | 0.08 | 0.08 | 0.03 | 0.03 | 0.57 | 0.57 | 0.43 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 102.45% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow Yield |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
0.00 | 0.00 | 10.50 | 0.01 | 14.28 | 0.76 | 5,239.40 | 529.63 | 56.53 | 3.75 |
Operating CF per Share |
(0.22) | (0.47) | (6,762.50) | (2.27) | (2,261.07) | (3.31) | (22,938.80) | (1,875.75) | (268.95) | (97.66) |
Capex per Share |
0.00 | 0.00 | (2,195.50) | 0.00 | (198.79) | 0.00 | (621.80) | 136.13 | (141.76) | (17.91) |
Free Cash Flow per Share |
(0.22) | (0.47) | (8,958.00) | (2.27) | (2,459.86) | (3.31) | (23,560.60) | (1,739.62) | (410.71) | (115.57) |
Cash per Share |
0.00 | 0.00 | 67.50 | 1.21 | 1,205.31 | 0.15 | 1,039.00 | 117.38 | 259.59 | 7.32 |
Shareholders Equity per Share |
0.00 | (1.74) | (25,159.50) | (0.76) | (759.10) | 7.77 | 53,800.40 | (4,786.12) | 288.95 | (174.03) |
Interest Debt per Share |
0.00 | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | (1.74) | (25,159.50) | (0.76) | (759.10) | 7.77 | 53,800.40 | (4,786.12) | 288.95 | (174.03) |
Free Cash Flow |
(0.64) | (1.35) | (1.79) | (6.56) | (7.13) | (11.47) | (11.78) | (1.39) | (6.08) | (7.96) |
Working Capital |
— | (2.60) | (2.60) | (4.29) | (4.29) | (5.53) | (5.53) | (8.37) | 1.42 | (2.60) |
Capital Expenditures |
(0.69) | (0.44) | (0.44) | (0.58) | (0.58) | (0.31) | (0.31) | 0.11 | (2.10) | (1.23) |
Net Current Asset Value |
— | (9.18) | (9.18) | (6.27) | (6.27) | (8.28) | (8.28) | (10.86) | 1.42 | (14.58) |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | 0.00 | 209.10 | 0.00 | 13.93 | 0.00 | 0.12 | (0.26) | 2.51 | 4.78 |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.00 | 0.07 | 0.15 | 0.08 | 0.16 | 0.29 | 0.31 | 1.70 | 0.17 | 0.18 |
Cash ROIC |
0.00% | (32.95%) | (46.89%) | (60.37%) | (68.45%) | (36.62%) | (37.87%) | (1,083.04%) | (71.75%) | (528.34%) |
Accounts Receivable Turnover |
— | 0.00 | 0.00 | 0.00 | 0.17 | 0.00 | 3.54 | 0.56 | 1.51 | 0.23 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.33 | 0.00 | 0.10 | 0.00 | (0.17) | 0.06 | 0.14 | 0.13 |
Inventory Turnover |
0.00 | 0.00 | 100.33 | 0.00 | 0.00 | 0.00 | (0.70) | 0.23 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 107.31 | 1,115.01 | 161.58 | 5,774.64 | 202.29 | (4,009.89) | 6,026.16 | 1,732.63 | 2,916.65 |
Days of Inventory on Hand |
0.00 | 0.35 | 3.64 | 0.00 | 0.00 | 52.88 | (1,048.22) | 1,289.37 | 0.00 | 0.00 |
Average Receivables |
— | — | — | — | 0.24 | 0.74 | 0.74 | 0.76 | 0.55 | 1.11 |
Average Payables |
— | — | 0.18 | 0.43 | 0.43 | 3.91 | 3.91 | 6.58 | 4.50 | 3.15 |
Average Inventory |
— | — | 0.00 | — | — | 0.93 | 0.93 | 1.58 | — | — |
Average Assets |
— | 2.14 | 4.27 | 6.16 | 6.16 | 23.52 | 23.52 | 23.92 | 8.38 | 7.05 |
Average Common Equity |
— | — | (5.03) | (3.62) | (3.62) | 12.35 | 12.35 | 11.54 | 0.22 | (3.86) |
Columns are period end dates · fundamentals updated 2 Oct 2026